Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04261673
Other study ID # PREDICT-AEDH
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 23, 2020
Est. completion date December 31, 2025

Study information

Verified date January 2023
Source RenJi Hospital
Contact Junfeng Feng, MD
Phone +8613611860825
Email fengjfmail@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although craniotomy provides a more complete evacuation of the acute epidural hematoma, there are insufficient data to support specific surgical treatment method. We aim to perform a multi-center, parallel-group randomized clinical trial to compare the outcome and cost-effectiveness of decompressive craniectomy versus craniotomy for the treatment of traumatic brain injury patients with cerebral herniation undergoing evacuation of an acute epidural hematoma.


Description:

The incidence of epidural hematoma (EDH) among traumatic brain injury (TBI) patients has been reported to be in the range of 2.7 to 4%. Among patients in coma, up to 9% harbored an EDH requiring craniotomy. The mortality in patients in all age groups and GCS scores undergoing surgery for evacuation of EDH is approximately 10%. The decision to operate on an acute EDH (AEDH) is usually based on the patient's GCS score, age, pupillary abnormalities, comorbidities, CT findings, associated intracranial lesions, in delayed decisions, the time between neurological deterioration and surgery, and intracranial pressure. An AEDH greater than 30 ml should be surgically evacuated regardless of the patient's Glasgow Coma Scale (GCS) score. There are insufficient data to support one surgical treatment method. However, craniotomy provides a more complete evacuation of the hematoma for patients with an AEDH that require an operation to remove the clot. But whether decompressive craniectomy (DC) should be employed still has considerable controversy. The choice of operative technique is influenced by the surgeon's expertise, training, and evaluation of a particular situation. The difference between these two procedures is that a bone flap is left out before closing the skin in DC. Both approaches are widely used among neurological surgeons (although the indications may differ), therefore there is sufficient experience in the centers to set up a randomized clinical trial.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Clear medical history of traumatic brain injury; 2. Within 12 hours after injury; 3. Unilateral mydriasis or bilateral mydriasis before the operation; 4. Supratentorial acute epidural hematoma on CT scan with midline shift, which is the leading cause of operation, despite associated other lighter intracranial injury (e.g., subarachnoid hemorrhage and contusion); 5. The admitting neurosurgeon considers that the epidural hematoma needs to be evacuated with a craniotomy or decompressive craniectomy. 6. With informed consent. Exclusion Criteria: 1. Previous intracranial surgery prior to trauma; 2. Patients with a score of 3 on the GCS, with bilateral fixed and dilated pupils, bleeding diathesis or defective coagulation, or other injuries that were deemed to be unsurvivable; 3. Patients who had injury of the oculomotor nerve; 4. Patients are considered to be operated mainly by following pathological change on CT: subdural hematoma, intracerebral hemorrhage, large size infarction, et al., but not because of epidural hematoma; 5. Severe pre-existing disability or severe co-morbidity which would lead to a poor outcome even if the patient is supposed to a good recovery from the TBI; 6. Pregnant female.

Study Design


Intervention

Procedure:
Decompressive Craniectomy
A large bone flap must be raised. The evacuation of epidural hematoma is depended on surgeon's preference. The bone flap should not be replaced at the end of the operation. DC has an advantage in controlling brain swelling, but patient is necessary to have another operation of cranioplasty to reconstruct the skull in the future.
Craniotomy
A large bone flap must be raised. The evacuation of epidural hematoma is depended on surgeon's preference. However, the bone flap must be replaced and fixed with fixation system (plates and screws). The patient will not need an additional operation to rebuild the skull in the future. But undisciplinable brain swelling and increased intracranial pressure may happen in some patients, and additional decompressive craniectomy is recommended in these cases.

Locations

Country Name City State
China Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai Shanghai

Sponsors (3)

Lead Sponsor Collaborator
RenJi Hospital Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shenzhen Second People's Hospital

Country where clinical trial is conducted

China, 

References & Publications (4)

Bullock MR, Chesnut R, Ghajar J, Gordon D, Hartl R, Newell DW, Servadei F, Walters BC, Wilberger JE; Surgical Management of Traumatic Brain Injury Author Group. Surgical management of acute epidural hematomas. Neurosurgery. 2006 Mar;58(3 Suppl):S7-15; discussion Si-iv. — View Citation

Li LM, Kolias AG, Guilfoyle MR, Timofeev I, Corteen EA, Pickard JD, Menon DK, Kirkpatrick PJ, Hutchinson PJ. Outcome following evacuation of acute subdural haematomas: a comparison of craniotomy with decompressive craniectomy. Acta Neurochir (Wien). 2012 Sep;154(9):1555-61. doi: 10.1007/s00701-012-1428-8. Epub 2012 Jun 30. — View Citation

Lin H, Wang WH, Hu LS, Li J, Luo F, Lin JM, Huang W, Zhang MS, Zhang Y, Hu K, Zheng JX. Novel Clinical Scale for Evaluating Pre-Operative Risk of Cerebral Herniation from Traumatic Epidural Hematoma. J Neurotrauma. 2016 Jun 1;33(11):1023-33. doi: 10.1089/neu.2014.3656. Epub 2016 Jan 28. — View Citation

Wang WH, Hu LS, Lin H, Li J, Luo F, Huang W, Lin JM, Cai GP, Liu CC. Risk factors for post-traumatic massive cerebral infarction secondary to space-occupying epidural hematoma. J Neurotrauma. 2014 Aug 15;31(16):1444-50. doi: 10.1089/neu.2013.3142. Epub 2014 Jun 25. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary GOSE (extended Glasgow Outcome Scale) scores The primary outcome is indicated by the long-term functional outcomes, including overall mortality and the score on the "Extended Glasgow Outcome Scale" (GOS-E). "Extended Glasgow Outcome Scale" is the unabbreviated scale title, minimum value is 1 and maximum value is 8, which was scored as follows and higher scores mean a better outcome:
death;
persistent vegetative state;
lower severe disability;
upper severe disability (stratum 3 and 4 were considered as severe disability, with permanent requirement for help with daily living);
lower moderate disability;
upper moderate disability (stratum 5 and 6 were considered as mild disability, without a need for assistance in everyday life, that might, however, require special equipment for employment);
lower good recovery;
upper good recovery (stratum 7 and 8 were considered as good recovery).
6 months post-injury
Secondary incidence of post-operative cerebral infarction Patients have clinical deterioration after an initial surgery because of post-operative cerebral infarction. within 6 months post-injury
Secondary incidence of additional craniocerebral surgery Patients have additional craniocerebral surgical operation as a result of clinical deterioration. within 6 months post-injury
Secondary length of stay in hospital The length of patient's stay in hospital after initial surgery, which must due to AEDH related medical treatment. Number of days in hospital are used to evaluate length, and patients with poor treatment effect may need longer hospital stays. within 6 months post-injury
Secondary detailed economic evaluation Total medical expense related to treatment of AEDH, including the costs of operations, hospitalization and rehabilitation. Different operations have different medical expense,and patients with poor treatment effect may need more medical expense. We record and evaluate the total medical expense of the entire AEDH treatment process, within 6 months post-injury. within 6 months post-injury
Secondary incidence of serious adverse events Serious adverse events (SAE) is defined as an untoward occurrence that:
results in death;
is life-threatening;
requires hospitalization or prolongation of existing hospitalization;
results in persistent or significant disability or incapacity;
is otherwise considered medically significant by the investigator.
within 6 months post-injury
Secondary quality of life (EQ-5D-5L) Unabbreviated scale title is "5-level EuroQol five dimensions" questionnaire. The EQ-5D is a generic instrument for describing and valuing health. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. at 1,3 and 6 months post-injury
Secondary MMSE (mini-mental state examination) scores Unabbreviated scale title is "mini-mental state examination", and minimum value is 0 and maximum value is 30. Higher scores mean a better outcome. at 1,3 and 6 months post-injury
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02880566 - Efficacy of Scalp Block on Hemodynamic Stability and Opioid Consumption During Craniotomy N/A
Completed NCT05103735 - Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity
Completed NCT04285359 - Impact of Severe Intraoperative Hyperglycemia on Infection Rate After Elective Intracranial Interventions
Completed NCT03364283 - Sitting Versus Horizontal Position on Craniotomies
Completed NCT01502540 - Pain Prevalence After Major Craniotomy N/A
Recruiting NCT06157359 - Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection N/A
Recruiting NCT01474304 - Intravenous Acetaminophen for Craniotomy Patients Phase 2
Completed NCT01617837 - The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy Phase 2/Phase 3
Recruiting NCT04229966 - Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases
Completed NCT01987648 - eCRANIO Trial Study on Elective CRAniotomies: Postoperative Neurointensive Care, Imaging and Outcome
Recruiting NCT05962684 - A Greek-designed ERAS Protocol in Elective Craniotomy
Completed NCT05940935 - The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations
Completed NCT03033706 - Intraoperative Goal Directed Fluid Management in Supratentorial Brain Tumor Craniotomy N/A
Completed NCT00658242 - Craniofacial Surgery Perioperative Registry N/A
Completed NCT04859907 - Bone Flap Fixation Systems For Craniotomy Procedures N/A
Active, not recruiting NCT02237716 - Rapid Intravenous Infusion of Mannitol Results in a Dipper-type Change in Stroke Volume Variation in Patients Undergoing Major Neurosurgery N/A
Recruiting NCT01966939 - Influences of Types of Skull Surgery on Temporomandibular Joint Performance N/A
Completed NCT01606969 - Comparison of Epinephrine-lidocaine Solution and Dexmedetomidine -Lidocaine Solution N/A
Completed NCT00590499 - Agitation in Post Operative Neurosurgical Patients N/A
Withdrawn NCT01282645 - Case Series to Evaluate Patient Specific Implants (PSI) in Polyether Ether Ketone (PEEK) Performance After 2 Years N/A